Rapid use of contactless technology during the pandemic led to services that were quicker, easier, and more seamless. In order to improve operations and save lives, this invention may also be used in the healthcare sector, according to Thomas Grellner, CEO of the German MedTech company Smedo.
Rellner claims that a range of complex electrocardiogram (ECG) devices that record a patient’s heart activity are currently being used to monitor patients in critical care units. These devices cost between $1,800 and $2,500 each, despite the fact that they are effective.
Rellner claims that a range of complex electrocardiogram (ECG) devices that record a patient’s heart activity are currently being used to monitor patients in critical care units. These devices cost between $1,800 and $2,500 each, despite the fact that they are effective.
The device, which can gather information up to seven meters away, can continuously record patients’ vital signs including heart rate, respiration, blood pressure, and temperature while simultaneously tracking information from many people in a room.
He asserts that by using a high-frequency band, the wave-emitting device is non-toxic and does not endanger the health of patients or medical personnel who could later analyze the gathered data.
The Berlin-based company said last month that a seed funding round of around €2 million ($2.1 million) had been completed. This money will be used to develop and market contactless devices in hospitals and nursing homes across the nation.